1. Home
  2. EOCN vs BGLC Comparison

EOCN vs BGLC Comparison

Compare EOCN & BGLC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

EOCN

Eocene Ltd. Ordinary Shares

N/A

Current Price

$3.50

Market Cap

3.6M

Sector

Health Care

ML Signal

N/A

Logo BioNexus Gene Lab Corp

BGLC

BioNexus Gene Lab Corp

HOLD

Current Price

$1.50

Market Cap

4.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EOCN
BGLC
Founded
N/A
2017
Country
Israel
Malaysia
Employees
6
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical Specialities
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.6M
4.3M
IPO Year
2014
2019

Fundamental Metrics

Financial Performance
Metric
EOCN
BGLC
Price
$3.50
$1.50
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
2.2K
4.2K
Earning Date
N/A
04-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
45.78
EPS
N/A
N/A
Revenue
N/A
$7,424,911.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.33
$1.07
52 Week High
$3.66
$6.10

Technical Indicators

Market Signals
Indicator
EOCN
BGLC
Relative Strength Index (RSI) N/A 48.26
Support Level N/A $1.23
Resistance Level N/A $1.61
Average True Range (ATR) 0.00 0.07
MACD 0.00 0.01
Stochastic Oscillator 0.00 59.11

Price Performance

Historical Comparison
EOCN
BGLC

About EOCN Eocene Ltd. Ordinary Shares

Eocene Ltd is a GI-focused medtech and biopharmaceutical company focused on advancing solutions across gastrointestinal disease management, GI oncology and related therapeutic areas. Its wholly owned subsidiary develops medical devices for postoperative colorectal care, including CG-100, an intraluminal bypass device intended to protect colorectal anastomoses and reduce the need for diverting stomas. The company's therapeutic portfolio includes Aramchol, a first-in-class synthetic fatty acid-bile acid conjugate molecule being evaluated in liver disease and oncology indications, including gastrointestinal cancers.

About BGLC BioNexus Gene Lab Corp

BioNexus Gene Lab Corp is a Wyoming corporation with two principal operating subsidiaries in Malaysia: Chemrex Corporation Sdn. Bhd. (Chemrex) and MRNA Scientific Sdn. Bhd. (MRNA Scientific). Chemrex is engaged in the distribution of chemical raw materials, mainly for industrial applications in Southeast Asia. MRNA Scientific is engaged in the development and provision of blood-based genomic screening services intended to support early disease risk assessment and health management. Trading of industrial chemicals- Includes trading of industrial chemicals. Provision for genomic screening services- includes in commercializing proprietary blood-based diagnostic test for early disease detection. Investment holding- Investment holding, are its segments.

Share on Social Networks: